Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-02-22
2010-10-26
Davis, Zinna N (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S141000
Reexamination Certificate
active
07820693
ABSTRACT:
The present invention provides a compound having high antitumor activity, which is useful for therapeutic and preventive agents effective for proliferative diseases such as cancer; a production method thereof; an intermediate compound useful for such production; and a pharmaceutical composition comprising such a compound. The present invention provides a compound represented by the formula (1):wherein X represents an aryl group or heteroaryl group which may be substituted, Cy represents a 4- to 7-membered monocyclic heterocyclic ring or a 8- to 10-membered condensed heterocyclic ring which may be substituted, and Z represents O, S, or NRa; or a prodrug thereof; or a pharmaceutically acceptable salt thereof; and a pharmaceutical and a pharmaceutical composition which comprise the compound.
REFERENCES:
patent: 4461773 (1984-07-01), Gregory
patent: 4942163 (1990-07-01), Behrens
patent: 2006/0205767 (2006-09-01), Wong et al.
patent: 2007/0185160 (2007-08-01), Hattori et al.
patent: 050827 (1982-05-01), None
patent: 9851307 (1998-11-01), None
patent: 9911624 (1999-03-01), None
patent: 2005018568 (2005-03-01), None
patent: 2005075431 (2005-08-01), None
patent: 2005075432 (2005-08-01), None
Won-Jea Cho, et al. “Synthesis and Biological Evaluation of 3-Arylisoquinolines as Antitumor Agents.” Bioorganic & Medicinal Chemistry Letters 8, 1998, p. 41-46.
Won-Jea Cho, et al. “Molecular Modeling of 3-Arylisoquinolines Antitumor Agents Active Against A-549. A Comparative Molecular Field Analysis Study.” Bioorganic & Medicinal Chemistry Letters 10, 2002, p. 2953-2961.
Alain Rose, et al. “Oxygen Heterocycles. Part XIII. From 3-Arylisocoumarins to 3-Arlisoquinones and 4Aryl-5H-2, 3-benzodiazepines.”J. Chem. Soc. (C),1968, p. 2205-2208.
Graham S. Poindexter. “Convenient Preparation of 3-Substituted 1(2H)-Isoquinolinones.” J. Org. Chem. 1982, 47, p. 3787-3788.
Won-Jea Gho. “Synthesis and Antitumor Activity of 3-Arylisoquinoline Derivatives.” Arch. Pharm. Res. vol. 20, No. 3, 1997, p. 264-268.
Seung Hoon Cheon, et al. “Structure-Activity Relationship Studies of Isoquinolinone Type Anticancer Agent.” Arch. Pharm. Res. vol. 24, No. 4, 2001, p. 276-208.
Thanh Nguyen Le, et al. “A Facile synthesis of benzo[c]phenanthiridine alkaloids: oxynitidine and oxysanguinarine using lithiated toluamide-benzonitrile cycloaddition.” Tetrahedron Letters 45, 2004, p. 2763-2766.
Thanh Nguyen Le, et al. “A versatile total synthesis of benzo[c]phenanthridine alkaloids using lithiated toluamide-benzonitrile cycloaddition.” J. Org. Chem., 2004, 69, 2768-2772.
John P. Wolfe, et al. “Simple, Efficient Catalyst System for the Palladium-Catalyzed Amination of Aryl Chlorides, Bromides, and Triflates.” J. Org. Chem. 2000, 65, p. 1158-1174.
Michele C. Harris, et al. “Improved Functional Group Compatibility in the Palladium-Catalyzed Synthesis of Aryl Amines.” Org. Letters, 2002, 4, p. 2885-2888.
Xaohua Huang, et al. “New Ammonia Equivalents for the Pd-Catalyzed Aminaton of Ayl Halides.” Org. Leters, 2001, 3, p. 3417-3419.
Kentaro Okano, et al. “Synthesis of Secondary Arylamines through Copper-Mediated Intermolecular Aryl Amination.” Org. Letters, 2003, 5, p. 4987-4990.
Artis Klapars, et al. “A General and Efficient Copper Catalyst for the Amidation of Aryl Halides and the N-Arylation of Nitrogen Heterocycles.” J. Am. Chem. Soc., 2001, 123, p. 7727-7729.
Artis Klapars, et al. “A General and Efficient Copper Catalyst for the Amidation of Aryl Halides.” J. Am. Chem. Soc., 2002, 124, 7421-7428.
Teruo Umemoto, et al. “Synthesis, Properties, and Reactivity of N,N-Difluorobipyridinium and Related Salts and Their Applications as Reactive and Easy-to-Handle Electrophilic Fluorinating Agents with High Effective Fluorine Content.” J. Org. Chem., 1998, 63, p. 3379-3385.
Noboru Yagi, et al. “Synthesis of N-Substituted-7-acylamino-3-phenylisocarbostyril and 6-Phenylbenzimidazor[2, 1-a]-isoquinoline Derivatives and their Fluorescence Spectra.” Yuki Gosei Kagaku Kyokaishi, 1969, 27, p. 51-58.
Thanh Nguyen, et al. “Synthesis of Oxychelerythrine Using Lithiated Toluamide-Benzonitrile Cycloaddition.” Chem. Pharm. Bull., 2005, 53, p. 118-120.
Thanh Nguyen, et al. “Total Synthesis of Oxyfagaronine, Phenolic Benza[c]phenanthridine and General Synthetic Way of 2,3,7,8- and 2,3,8,9-Tetrasubstituted Benzo[c]phenanthridine Alkaloids.” Chem. Pahrm. Bull., 2006, 54, p. 476-480.
Tuanli Yao, et al. “Regio- and Stereoselective Synthesis of Isoindolin-1-ones via Electrophilic Cyclization.” J. Org. Chem., 2005, 70, p. 1432-1437.
Jonathan L. Hartwell. “o-Chlorobromobenzene.” Org. Synth. Collective, vol. 3, 1955, p. 185-187.
Peter J. Harrington, et al. “Palladium-Catalyzed Reactions in the Synthesis of 3- and 4-Substituted Indoles. Approaches to Ergot Alkaloids.” J. Org. Chem., 1984, 49, p. 2657-2662.
Jingjun Yin, et al. “Palladium-Catalyzed Intermolecular Coupling of Aryl Halides and Amides.” Org. Letters, 2000, 2, p. 1101-1104.
R. Greg Browning, et al. “Synhess of chra N-aryl pyrroidinones via a palladium-catayzed cross-couping reaction.” Tetrahedron Letters, 2001, 42, p. 7155-7157.
Dominique Delaunay, et al. “Reactivity of β-Amino Alcohols with Carbon Disulfide. Study on the Synthesis of 2-Oxazolidinethiones and 2-Thiazolidinethiones.” J. Org. Chem., 1995, 60, p. 6604-6607.
Mojmir Suchy, et al. “Synthesis, Absolute Configuration, and Enantiomeric Enrichment of a Cruciferous Oxindole Phytoalexin, (S)-(−)-Spirobrassinin, and Its Oxazoline Analog.” J. Org. Chem., 2001, 66, p. 3940-3947.
Toshiya Morie, et al. “Asymmetric Synthesis of the Enantiomers of 2-Aminomethyl-4-(4-Fluorobenzyl) Morpholine, and Intermediate of Mosapride, a Gastroprokinetic Agent.” Heterocycles, 1994, 38, p. 1033-1040.
Edwin J. Iwanowicz, et al. “Novel Guanidine-Based Inhibitors of Inosine Monophosphate Dehydrogenase.” Bioorganic & Medicinal Chemistry Letters, 12, 2002, p. 2931-2934.
Qun Sun, et al. “Single Bead IR Monitoring or a Novel Benzimidazole Synthesis.” Bioorganic & Medicinal Chemistry Letters, 8, 1998, p. 361-364.
John J. Baldwin, et al. “β1-Selective Adrenoceptor Antagonists: Example of the 2-[4-[3-(Substituted amino)-2-hydroxypropoxy]phenyl]imidazole Class. 2.” J. Med. Chem., 1986, 29, p. 1065-1080.
Marlys Hammond, et al. “Structure-Activity Relationships in a Series of NPY Y5 Antagonists: 3-Amido-9-ethylcarazoles, Core-Modified Analogues and Amide Isosteres.” Bioorganic & Medicinal Chemistry Letters, 13, 2001, p. 1989-1992.
P.C. Reeves, et al. Jikken Kagaku Koza, Fourth Series, vol. 22, 1992, p. 43-82.
Keisike Kurita, et al. “Trichloromethyl Chloroformate as a Phosgene Equivalent: 3-Isocyanatopopanoyl Chloride.” Org. Synth. Collective, col. 6, 1988, p. 715-718.
Y. Watanabe, et al. Jikken Kagaku Koza, Fourth Series, vol. 20, 1992, p. 358-359.
Ulrike Peters, et al. “Platelet Activating Factor Synthetic Studies.” Tetrahedron, 1987, 43, p. 3803-3816.
Edward J. Glamkowski, et al . “7-(Aminoacyl) and 7-(Aminoalkyl) Derivatives of 1, 2,6,7-Tetrahydoindolo [1,7-ab] ,[1,5]benzodiazepines as Potential Antidepressant Agents.” Bioorg. Med. Chem., 1980, 23, p. 1380-1386.
N. Selvakumar, et al. “Influence of Ethylene-Oxy Spacer Group on the Activity of Linezolid: Synthesis of Potent Antibacterials Possessing a Thiocarbonyl Group.” Bioorg. Med. Chem. Letters, 2003, 13, p. 4167-4172.
John Boot, et al. “Discovery and strucure-activity relationships of novel selectve norepinephrine and dual serotonin
orepinephrine reuptake inhibitors.” Bioorg. Med. Chem. Letters, 2005, 15, p. 699-703.
Daniela Spera, et al. “Estradiol derivatives bearing sulfur-containing substituen
Hattori Kazuo
Kondoh Osamu
Koyama Kohei
Masubuchi Miyako
Niizuma Satoshi
Browdy and Neimark PLLC
Chugai Seiyaku Kabushiki Kaisha
Davis Zinna N
LandOfFree
1-(2H)-isoquinolone derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 1-(2H)-isoquinolone derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1-(2H)-isoquinolone derivative will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4150930